Pharmacotherapy for obesity: novel agents and paradigms.
about
Roux-en-Y gastric bypass: effects on feeding behavior and underlying mechanismsAnti-ghrelin antibodies in appetite suppression: recent advances in obesity pharmacotherapyA selective review of glutamate pharmacological therapy in obsessive-compulsive and related disorders.Next generation of weight management medications: implications for diabetes and CVD riskAddressing Pediatric Obesity in Ambulatory Care: Where Are We and Where Are We Going?Regulation of food intake by mechanosensory ion channels in enteric neuronsObesity Education Strategies for Cancer Prevention in Women's Health.Ribose Accelerates Gut Motility and Suppresses Mouse Body Weight GainingLiraglutide prevents fast weight gain and β-cell dysfunction in male catch-up growth ratsGLP-1: a mediator of the beneficial metabolic effects of bariatric surgery?New perspectives on the development of antiobesity drugs.Epidemiology of Obesity and Pharmacologic Treatment Options.Evolution of pharmacological obesity treatments: focus on adverse side-effect profiles.Recent Trends in Endoscopic Management of Obesity.Effect of lorcaserin on glycemic parameters in patients with type 2 diabetes mellitus.Bariatric endoscopy: current state of the art, emerging technologies, and challenges.Novel lipidized analogs of prolactin-releasing peptide have prolonged half-lives and exert anti-obesity effects after peripheral administration.Need for a paradigm shift in adult overweight and obesity management - an EASO position statement on a pressing public health, clinical and scientific challenge in Europe.2014 EASO Position Statement on the Use of Anti-Obesity Drugs.Assessment of Weight Management Practices among Adults in the United Arab Emirates.Management of obesity after spinal cord injury: a systematic review.Peptide-functionalized nanoparticles for the selective induction of apoptosis in target cells.
P2860
Q27000617-83BFB20F-BAF1-41C4-BC9C-B24EC9D5376DQ27023771-27670C73-C47E-4DCB-8C5F-4EF8B53A2167Q28082048-3328297F-8283-4BEE-A015-0ABAC0AEA0EBQ28082858-350BC4EE-1C89-4896-942F-6EA7E7998218Q33872440-220A1B8D-E6B0-430B-8E69-DAD66D29A927Q34477578-BC443FB3-4FD1-4087-95AC-4ABA164103EBQ36567721-D4E74E98-C980-4FF4-A184-10F712B42EFAQ36911092-D736372B-FC64-4CC5-9377-8B0700D27205Q37071404-7A9688C0-A1F8-4DCC-8817-4C2A7FA209B9Q38307449-6FCC5B11-5281-44F3-81E7-F4EC21F4862CQ38397340-1782F07C-D4E0-4DA0-94BC-9EB1926C8B48Q38717129-F0716255-6048-45D4-BBA5-9FB292A27F56Q38758765-D59C20DF-52DF-4BC0-89C1-22423EC8DDA7Q38806795-A5F65C62-0783-4B89-AAE9-9D16AC53F221Q38874390-0AA958EC-7DF9-4C1D-BF5D-4E270F5E497AQ39084177-F82BE0AA-4496-4525-BC69-1114AEE6DE89Q41221501-5887AAAF-EA32-4BAC-BC64-AAF8FC28762EQ46244315-ED618491-2F53-470F-A18C-75096A4A16D1Q47129264-9F877749-ED9C-41DB-B83A-12197C1E1A50Q47151755-1A03DDCE-FB97-49DD-9E8E-D6D6DCFF616DQ47655595-0F267C9C-306D-4CB2-84C1-551D912BF564Q50932492-C77C4551-0421-44F1-BF17-525CAC61F53F
P2860
Pharmacotherapy for obesity: novel agents and paradigms.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on May 2014
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Pharmacotherapy for obesity: novel agents and paradigms.
@en
Pharmacotherapy for obesity: novel agents and paradigms.
@nl
type
label
Pharmacotherapy for obesity: novel agents and paradigms.
@en
Pharmacotherapy for obesity: novel agents and paradigms.
@nl
prefLabel
Pharmacotherapy for obesity: novel agents and paradigms.
@en
Pharmacotherapy for obesity: novel agents and paradigms.
@nl
P2860
P356
P1476
Pharmacotherapy for obesity: novel agents and paradigms.
@en
P2093
Andrea Pucci
Sean Manning
P2860
P304
P356
10.1177/2040622314522848
P50
P577
2014-05-01T00:00:00Z